The new E-Z Integrated Key Cup 10 Panel Test Cup is a fully integrated, self contained drug screening cup for detecting drugs and drug metabolites in urine. The E-Z Integrated Key Cup testing process is simply taking the urine specimens during the collection process. The E-Z Integrated Key Cup 10 Panel Drug Test is an affordable split specimen drug testing solution that provides a quality screening method with (99%) accurate results. The E-Z Integrated Key Cup is the first immediate response on site testing device to offer a compact, split specimen format that is not only easy to use, but is easy to administer for both sexes. Because of its compact and oval shape front and squared back, the E-Z Key Cup Drug Test is as easy to use for women and men. The E-Z Integrated Key Cup testing process is simply taking the urine specimens during the collection process.
E-Z Key Cup is the first immediate response on site testing device to offer a compact, split-specimen format that is not only easy to use, but is easy to administer for both sexes. Because of its compact and oval shape front and squared back, the Integrated Key Cup 10 panel drug test cup is as easy to use for women and men. The E-Z Integrated Key Cup 10 Panel Key Cup has a key that moves into the side of the cup. The Split key cup is an innovative drug test design that eliminates urine handling and donor tampering, providing a unique and efficient approach for on-site testing. The E-Z split key cup can be ordered with the combinations you want to test for.
Advantages of the E-Z split key cup. The following are the major advantages of E-Z split key cup: The Split Key Cup are easy to test and less expensive. The E-Z Integrated Key Cup specimen collector can activate the test with special key, thus donor manipulation can be eliminated. The E-Z Key Cup Label hides test result from those who do not need to view results. The Fully Integrated design of the 10 Panel Key Cup eliminates handling of the urine. Cut-offs levels of drug testing set according SAMHSA.
The E-Z Key cup is one our most economical immediate response drug screening products. The split key cup is initiated when the key is inserted into the cup. The E-Z Key Cup 10 Panel hinged lid seals the cup and keeps the urine locked in. The E-Z split key cup allows you to run drug tests at your convenience. The Split Key Cup is the first immediate response on site testing device to offer a compact, split-specimen format that is not only easy to use, but is easy to administer. I E-Z The split key cup is a fully integrated, self contained drug screening cup for detecting drugs and drug metabolites in urine. The E-Z key cup detects multiple drugs existence, as accurate as the laboratory tests in a shorter time. The E-Z split key cup also has an advantage that when the specimen is placed in the cup, the examiner can record the reading of the temperature strip.
No handling of the urine is required Leak proof snap top lid Integrated key cup Temperature Strip Auto-Split sample for specimen integrity No dipping, tilting, or touching, Results in 3-5 minutes. This product is known as the Split Key Cup, Split Specimen Cup, Integrated Cup, Easy Key Cup,Integrated Split Specimen Cup, E-Z key cup, Acon key cup, E-Z integrated split key cup, E-Z cup, E-Z split key cup, E-Z integrated key cup, rapid test cup. Integrated Key Cup is an affordable drug testing solution. Split Key Cup offers a compact, split-specimen format. E-Z key cup detects multiple drugs E-Z Split Specimen 10 panel comes available in CLIA waived configurations. The E-Z Integrated Key Cup is a widely used drug test devices, as they are available at low cost and are convenient and easy to use. They are also fast and accurate in reporting in just a few minutes.
PRINCIPLE
The E-Z key cup is an immunoassay based on the principle of competitive binding. Drugs which may be present in the urine specimen compete against their respective drug conjugate for binding sites on their specific antibody. During testing, a urine specimen migrates upward by capillary action. A drug, if present in the urine specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test line region of the specific drug strip.
The presence of drug above the cut-off concentration will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test line region. A drug-positive urine specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative urine specimen will generate a line in the test line region because of the absence of drug competition. To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.
REAGENTS
The Integrated key cup contains a membrane strip coated with drug-protein conjugates (purified bovine albumin) on the test line, a goat polyclonal antibody against gold-protein conjugate at the control line, and a dye pad which contains colloidal gold particles coated with mouse monoclonal antibody specific to the drugs being tested.
QUALITY CONTROL
A procedural control is included in the Integrated key cup. A red line appearing in the control region (C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique. Control standards are not supplied with this kit. However, it is recommended that positive and negative controls be tested as good laboratory practice to confirm the test procedure and to verify proper test performance.
Accuracy
A side-by-side comparison was conducted using the Integrated key cup and commercially available drug rapid tests. Testing was performed on approximately 300 specimens per drug type previously collected from subjects presenting for Drug Screen Testing. Presumptive positive results were confirmed by GC/MS. The following compounds were quantified by GC/MS and contributed to the total amount of drugs found in presumptive positive urine samples tested.
Forty (40) clinical samples for each drug were run using each of The Integrated key cup by an untrained operator at a Professional Point of Care site. Based on GC/MS data, the operator obtained statistically similar Positive Agreement, Negative Agreement and Overall Agreement rates as trained laboratory personnel.
Precision
A study was conducted at three physician offices by untrained operators using three different lots of product to demonstrate the within run, between run and between operator precision. An identical panel of coded specimens, containing drugs at the concentration of ± 50% and ± 25% cut-off level, was labeled, blinded and tested at each site.
Fifteen (15) urine samples of normal, high, and low specific gravity ranges (1.000-1.037) were spiked with drugs at 50% below and 50% above cut-off levels respectively. The Integrated key cup was tested in duplicate using fifteen drug-free urine and spiked urine samples. The results demonstrate that varying ranges of urinary specific gravity does not affect the test results.
Effect of the Urinary pH
The pH of an aliquoted negative urine pool was adjusted to a pH range of 5 to 9 in 1 pH unit increments and spiked with drugs at 50% below and 50% above cut-off levels. The spiked, pH-adjusted urine was tested with the Integrated key cup. The results demonstrate that varying ranges of pH does not interfere with the performance of the test.
Cross-Reactivity
A study was conducted to determine the cross-reactivity of the test with compounds in either drug-free urine or drug positive urine containing drugs of abuse.
